Formats
  1. Journal Article (67197)
  2. Meeting Abstract (33961)
  3. Book Section (5131)
  4. Review (3849)
  5. Editorial (2234)
  6. Conference Paper (1529)
  7. Guidelines (682)
  8. Correspondence (676)
  9. Research Letter (563)
  10. Book Whole (346)
  11. Miscellaneous (344)
Groups
  1. Department of Medicine (39434)
  2. GSK Faculty (22620)
  3. Solid Tumor Oncology Division (22241)
  4. Surgery (21399)
  5. Survivorship Research (15894)
  6. Sloan Kettering Institute Faculty (15707)

More Groups

People
  1. Marc Ladanyi (1332)
  2. Robert Motzer (1247)
  3. Victor Reuter (1229)
  4. Howard Scher (1130)
  5. Sergio Giralt (1065)
  6. Murray Brennan (1059)

More People

Years
  1. 2026 (7)
  2. 2025 (2817)
  3. 2024 (5600)
  4. 2023 (5809)
  5. 2022 (6169)
  6. 2021 (5720)

More Years

Publications
  1. Journal of Clinical Oncology (8683)
  2. Blood (5169)
  3. Cancer Research (2703)
  4. International Journal of Radiation Oncology, Biology, Physics (2619)
  5. Laboratory Investigation (1890)
  6. Modern Pathology (1817)

More Publications

Publishers
  1. Elsevier Inc. (13940)
  2. American Society of Clinical Oncology (9275)
  3. Springer (7226)
  4. Nature Publishing Group (6437)
  5. American Association for Cancer Research (6026)
  6. American Society of Hematology (5550)

More Publishers

Results (116512)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Curating cartography: Enabling the harmonisation, visualisation, and reuse of diverse multiplexed imaging data through the Human Tumor Atlas Network Data Coordinating Center
    Meeting Abstract

    Taylor, A. J.; Nikolov, M.; de Brujin, I.; Muhlich, J.; De Felice, M.; Sokolov, A.; Schapiro, D.; Sorger, P.; Bletz, J.; Schultz, N.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • TERT mutant promoter mouse model induces cancer progression in Braf(V600E)-driven thyroid tumors: A novel tool to understand the biology of telomerase-reactivated cancers
    Meeting Abstract

    Landa, I.; Hao, J. Z.; Xu, B.; Giacalone, J.; Herbert, Z.; Blasco, M. A.; Knauf, J. A.; Ghossein, R.; Fagin, J. A.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Frequent 4EBP1 amplification induces synthetic dependence on FGFR signaling in cancer
    Meeting Abstract

    Singh, K.; Mohan, P.; Sanghvi, V. R.; Ciriello, G.; Lailler, N.; de Stanchina, E.; Wendel, H. G.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Organic anion transporter(SLCO)genotype and prostate cancer progression: Prospective cohort study and meta-analysis
    Meeting Abstract

    Stopsack, K. H.; Rajanala, H.; Plym, A.; Vaselkiv, J. B.; Matsoukas, K.; Ebot, E. M.; Markt, S. C.; Penney, K. L.; Lee, G. S. M.; Mucci, L. A.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Synthetic lethality by targeting ribonucleotide reductase in PP2A deficient uterine serous carcinoma
    Meeting Abstract

    O'Connor, C. M.; Taylor, S. E.; Miller, K. M.; Hurst, L.; Haanen, T. J.; Suhan, T. K.; Zawacki, K. P.; Noto, F. K.; Trako, J.; Mohan, A.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Switching inhibitor class overcomes crizotinib resistance in a MET fusion-positive NSCLC with a novel acquired MET G1090A mutation
    Meeting Abstract

    Murciano-Goroff, Y. R.; Kannan, S.; Chang, J. C.; Benayed, R.; Blokhin, I.; Rekhtman, N.; Sisk, A. E.; Gibson, J.; Judka, L.; Kaplanis, L.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Chemotherapy-related mutational signatures reveal the origins of therapy-related myeloid neoplasms
    Meeting Abstract

    Diamond, B.; Ziccheddu, B.; Boyle, E. M.; Maclachlan, K.; Taylor, J.; Watts, J. M.; Lu, S. X.; Coffey, D. G.; Bolli, N.; Papaemmanuil, E.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Genomic heterogeneity as a barrier to precision oncology in urothelial cancer
    Meeting Abstract

    Chen, Z.; Clinton, T. N.; Park, S.; Lenis, A. T.; Donoghue, M.; Rosenberg, J. E.; Dean, B. F.; Teo, M. Y.; Bochner, B. H.; Ostrovnaya, I.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Beta-catenin and PDGFRB modulate HIF1a in desmoid cells to promote sorafenib-sensitive paracrine signaling pathways
    Meeting Abstract

    Hu, J.; Villano, A.; Connor, R.; Rozenberg, Y.; Venkatesh, A.; Socci, N.; Singer, S.; Crago, A.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Widespread hypertranscription in aggressive human cancer
    Meeting Abstract

    Zatzman, M.; Fuligni, F.; Ripsman, R.; Suwal, T.; Edward, L. M.; Denroche, R.; Jang, G. H.; Notta, F.; Gallinger, S.; Selvanathan, S. P.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save